Tests aspirin in people with long-term heart artery disease
Tests aspirin in adults with stable chest pain from coronary artery disease.
Plain-language title generated from the registry record
Registry title: Efficacy and Safety of Aspirin in Patients With Chronic Coronary Syndromes Without Revascularization
Key facts
- Where
- Kyoto, JapanSee the site
- Phase
- Phase 4
Where in Japan
- Kyoto University HospitalKyoto, JapanTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Takeshi Morimoto
- Trial code
- NCT05347069
- Record updated
- 11 March 2025
- Original description
The purpose of this study is to evaluate the efficacy and safety aspirin in patients with chronic coronary syndromes without revascularization.Read full original descriptionShow less
Efficacy and Safety of Aspirin in Patients With Chronic Coronary Syndromes Without Revascularization
The purpose of this study is to evaluate the efficacy and safety aspirin in patients with chronic coronary syndromes without revascularization.
Inclusion: Patients with chronic coronary syndromes with ≧50% diameter stenosis in one or more major coronary vessels/major branches on coronary CT or coronary angiography but not eligible for coronary revascularization; Patients for whom consent can be obtained.
Exclusion: Patients undergoing antithrombotic therapy other than aspirin; Patients scheduled for major surgical procedures that will require aspirin discontinuation; Patients with history of acute coronary syndromes (ACS); Patients with history of percutaneous coronary intervention (PCI) or coronary artery bypass graft (CABG); Patients with history of stroke within six months; Patients with left main trunk stenosis (≥50%); Patients for whom aspirin administration is mandatory; Patients with atrial fibrillation; Patients with contraindication of aspirin; Patients expected to have a prognosis of 1 year or less due to comorbidities; Women of child-bearing potential or women who have a positive pregnancy test at enrolment or randomization; Patients who are judged by attending physicians to be inappropriate to participate in this study.